1. Guo, Jun, Shi, Junping, Yao, Ming, Wang, Kai, Jiang, Da. . A rare double ALK fusion variant EML4-ALK and CDK15-ALK in lung adenocarcinoma and response to crizotinib: A case report. In Medicine, 99, e22631. doi:10.1097/MD.0000000000022631. https://pubmed.ncbi.nlm.nih.gov/33157918/
2. Shiraishi, Yuichi, Fujimoto, Akihiro, Furuta, Mayuko, Miyano, Satoru, Nakagawa, Hidewaki. 2014. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers. In PloS one, 9, e114263. doi:10.1371/journal.pone.0114263. https://pubmed.ncbi.nlm.nih.gov/25526364/
3. Dasgupta, Debanjali, Mahadev Bhat, Sanjana, Creighton, Claire, Delmotte, Philippe, Sieck, Gary C. 2023. Molecular mechanisms underlying TNFα-induced mitochondrial fragmentation in human airway smooth muscle cells. In American journal of physiology. Lung cellular and molecular physiology, 326, L190-L205. doi:10.1152/ajplung.00198.2023. https://pubmed.ncbi.nlm.nih.gov/38084427/
4. Mao, Jianshui, Li, Hui-Min, Huang, Zhidan. 2024. Comprehensive analysis of the expression and prognosis for cyclin-dependent protein kinase family in osteosarcoma. In Nucleosides, nucleotides & nucleic acids, , 1-24. doi:10.1080/15257770.2024.2410957. https://pubmed.ncbi.nlm.nih.gov/39357043/
5. Nguyen, Tri K, Grant, Steven. 2013. Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism. In Molecular cancer therapeutics, 13, 662-74. doi:10.1158/1535-7163.MCT-13-0714. https://pubmed.ncbi.nlm.nih.gov/24362465/
智鼠故事 
